News

A publication by scientists of the Anticancer Fund

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients

Ciska Verbaanderd, Ilse Rooman, Lydie Meheus, Isabelle Huys - On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients. Frontiers in Pharmacology, 31 January 2020, DOI: 10.3389/fphar.2019.01664

Transparancy of clinical trial reports assured

Clinical trials should remain transparent

A publication by scientists of the Anticancer Fund

Biased by design? Clinical trials and patient benefit in oncology

Pan Pantziarka, Ciska Verbaanderd, Lydie Meheus - Biased by design? Clinical trials and patient benefit in oncology. Future Medicine, 16 (3), doi.org/10.2217/fon-2019-0763

Brand-new patient-focussed website coming up in 2018

In December 2017, ACF reworked its website aimed at medical professionals and stakeholders. The updated site focusses on our mission, tools and project portfolio. For reasons of clarity, general information for patients (such as patient guides, educational articles on cancer treatments, new findings in cancer research, in the news, etc.) has been extracted from ACF’s reworked website. Instead, we will launch an additional website that is dedicated to patients only. This patient website will be a stand-alone with accessible content for patients, family members and community members. This website is scheduled for launch in early 2018. We hope you find all the information you need on the new site, and we welcome any feedback that you might have!

SAVE THE DATE - roundtable on drug repurposing at European Parliament